Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.
Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.
While the medicinal cannabis industry continues to rapidly advance and expand operations by identifying new leading edge products, leaders are turning towards the expertise and knowledge of other medical sectors, especially with influence from the biopharma sector.
InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.
The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.
As a result, M&A activity in the market is heading toward exponential growth as well.
In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?
Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.
Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.
ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward.
Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
Tetra Bio-Pharma Inc. (CSE: TBP, OTC:GRPOF) and IntelGenx Corp. (TSXV:IGX, OTCQX:IGXT), annouced the signing of a binding term sheet for the development and commercialization of a drug product containing dronabinol.
Tweet Share SEATTLE, WA / ACCESSWIRE / February 7, 2017 / SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, today announces that the Company is officially debt-free. In conjunction, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure additional funding of $1 million.
Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.
The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.
BY KYLE POTTER ASSOCIATED PRESS
ST. PAUL, Minn. (AP) — Prosecutors in Minnesota filed felony charges Monday against two former officials from one of the state’s licensed medical marijuana manufacturers for allegedly shipping marijuana oil to a subsidiary facility in New York.
Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.
Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.
